Yasmin, Ephia

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility

Tang, T., Lord, J. M., Norman, R. J., Yasmin, E., & Balen, A. H. (2012) · Cochrane Database of Systematic Reviews

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 698

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility

Morley, L. C., Tang, T., Yasmin, E., Norman, R. J., & Balen, A. H. (2017) · Cochrane Database of Systematic Reviews

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 296

Defining hyperandrogenism in polycystic ovary syndrome: measurement of testosterone and androstenedione by liquid chromatography–tandem mass spectrometry and analysis by receiver operator characteristic plots

Barth, J. H., Field, H. P., Yasmin, E., & Balen, A. H. (2010) · European Journal of Endocrinology

Ovarian function and disordersAdrenal Hormones and Disorders

Cited by 69

Reduced uterine volume after induction of puberty in women with hypogonadism

Burt, E., Davies, M. C., Yasmin, E., Cameron‐Pimblett, A., Mavrelos, D., Talaulikar, V., & Conway, G. S. (2019) · Clinical Endocrinology

Hypothalamic control of reproductive hormonesSexual Differentiation and Disorders

Cited by 25